Influenza A Virus, H1N1 Subtype
"Influenza A Virus, H1N1 Subtype" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 1 and neuraminidase 1. The H1N1 subtype was responsible for the Spanish flu pandemic of 1918.
Below are MeSH descriptors whose meaning is more general than "Influenza A Virus, H1N1 Subtype".
Below are MeSH descriptors whose meaning is more specific than "Influenza A Virus, H1N1 Subtype".
This graph shows the total number of publications written about "Influenza A Virus, H1N1 Subtype" by people in Harvard Catalyst Profiles by year, and whether "Influenza A Virus, H1N1 Subtype" was a major or minor topic of these publication.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
Below are the most recent publications written about "Influenza A Virus, H1N1 Subtype" by people in Profiles.
Label-free detection and discrimination of respiratory pathogens based on electrochemical synthesis of biomaterials-mediated plasmonic composites and machine learning analysis. Biosens Bioelectron. 2023 May 01; 227:115178.
IFI27 transcription is an early predictor for COVID-19 outcomes, a multi-cohort observational study. Front Immunol. 2022; 13:1060438.
A prophylactic effect of aluminium-based adjuvants against respiratory viruses via priming local innate immunity. Emerg Microbes Infect. 2022 Dec; 11(1):914-925.
Increased incidence of pediatric narcolepsy following the 2009 H1N1 pandemic: a report from the pediatric working group of the sleep research network. Sleep. 2022 09 08; 45(9).
Permanent, Antimicrobial Coating to Rapidly Kill and Prevent Transmission of Bacteria, Fungi, Influenza, and SARS-CoV-2. ACS Appl Mater Interfaces. 2022 Sep 21; 14(37):42483-42493.
Identification of a cross-neutralizing antibody that targets the receptor binding site of H1N1 and H5N1 influenza viruses. Nat Commun. 2022 09 02; 13(1):5182.
Vaccine Effectiveness Against Life-Threatening Influenza Illness in US Children. Clin Infect Dis. 2022 08 25; 75(2):230-238.
Investigation of CD4 and CD8 T cell-mediated protection against influenza A virus in a cohort study. BMC Med. 2022 07 21; 20(1):230.
Greater Breadth of Vaccine-Induced Immunity in Females than Males Is Mediated by Increased Antibody Diversity in Germinal Center B Cells. mBio. 2022 08 30; 13(4):e0183922.
Membrane-Tethered Mucin 1 Is Stimulated by Interferon and Virus Infection in Multiple Cell Types and Inhibits Influenza A Virus Infection in Human Airway Epithelium. mBio. 2022 08 30; 13(4):e0105522.